CytoMed (GDTC): Pre-Market Stock Surge Amid Strategic Moves
Shares of CytoMed Therapeutics Limited (NASDAQ: GDTC) are experiencing a significant uptick in the US stock market. As of the latest pre-market session, GDTC stock has risen by 17.65%, reaching $2.40. This surge follows the company’s announcement of multiple strategic developments. Acquisition of Cellsafe International’s Assets CytoMed, through its wholly owned subsidiary IPSC Depository Sdn […]
CytoMed (GDTC): Pre-Market Stock Surge Amid Strategic Moves Read More »